Catalyst Biosciences (FRA:HGF2) 3-Year EBITDA Growth Rate : 40.50% (As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Catalyst Biosciences 3-Year EBITDA Growth Rate?

Catalyst Biosciences's EBITDA per Share for the three months ended in Sep. 2023 was €-0.04.

During the past 3 years, the average EBITDA Per Share Growth Rate was 40.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 23.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 33.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Catalyst Biosciences was 81.80% per year. The lowest was -69.30% per year. And the median was 40.50% per year.

Competitive Comparison of Catalyst Biosciences's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Catalyst Biosciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Catalyst Biosciences's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Catalyst Biosciences's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Catalyst Biosciences's 3-Year EBITDA Growth Rate falls into.

Catalyst Biosciences 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Catalyst Biosciences (FRA:HGF2) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Catalyst Biosciences 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Catalyst Biosciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Catalyst Biosciences (FRA:HGF2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Catalyst Biosciences Inc (FRA:HGF2) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

611 Gateway Boulevard, Suite 710, South San Francisco, CA, USA, 94080

Website

https://www.catalystbiosciences.com

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants.

Catalyst Biosciences (FRA:HGF2) Headlines

No Headlines